142 related articles for article (PubMed ID: 37550179)
21. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
22. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
[No Abstract] [Full Text] [Related]
23. Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stage.
Patel HD; Man A; Koehne EL; Rac G; Aragao AP; Flanigan RC; Gorbonos A; Gupta GN; Woods ME; Picken MM; Quek ML
Urol Oncol; 2022 Jul; 40(7):347.e1-347.e8. PubMed ID: 35551862
[TBL] [Abstract][Full Text] [Related]
24. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
25. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
26. Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma.
Yan Y; Liu L; Zhou J; Li L; Li Y; Chen M; Wang L; He W; Guan X; Zu X; Qi L
J Cancer Res Clin Oncol; 2015 Feb; 141(2):345-52. PubMed ID: 25178995
[TBL] [Abstract][Full Text] [Related]
27. Sarcomatoid renal cell carcinoma: MRI features and their association with survival.
Cheng M; Duzgol C; Kim TH; Ghafoor S; Becker AS; Causa Andrieu PI; Gangai N; Jiang H; Hakimi AA; Vargas HA; Woo S
Cancer Imaging; 2023 Feb; 23(1):16. PubMed ID: 36793052
[TBL] [Abstract][Full Text] [Related]
28. A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality.
Palumbo C; Mazzone E; Mistretta FA; Knipper S; Perrotte P; Shariat SF; Saad F; Kapoor A; Lattouf JB; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Clin Genitourin Cancer; 2020 Aug; 18(4):314-321.e1. PubMed ID: 32482565
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
[TBL] [Abstract][Full Text] [Related]
30. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
Aron M; Nguyen MM; Stein RJ; Gill IS
Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
[TBL] [Abstract][Full Text] [Related]
31. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
[TBL] [Abstract][Full Text] [Related]
32. Unclassified renal cell carcinoma: a report of 56 cases.
Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
[TBL] [Abstract][Full Text] [Related]
33. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
34. Pathobiology and prognosis of chromophobe renal cell carcinoma.
Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.
Lebacle C; Pooli A; Bessede T; Irani J; Pantuck AJ; Drakaki A
World J Urol; 2019 Jan; 37(1):115-123. PubMed ID: 29858701
[TBL] [Abstract][Full Text] [Related]
36. [Sarcomatoid renal cell carcinoma with von Hippel-Lindau disease: a case report].
Minagawa T; Nishizawa S; Kamigaito M; Nakayama T; Okaneya T
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):723-6. PubMed ID: 17682453
[TBL] [Abstract][Full Text] [Related]
37. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
38. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
39. Sarcomatoid renal cell carcinoma. A treatable entity.
Sella A; Logothetis CJ; Ro JY; Swanson DA; Samuels ML
Cancer; 1987 Sep; 60(6):1313-8. PubMed ID: 2441841
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]